HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

2nd Edition of International Cancer Research Conference

March 19-21, 2026 | Singapore

March 19 -21, 2026 | Singapore

Adrenocortical Carcinoma

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC), a rare cancer originating in the adrenal cortex, comprises a minute fraction of overall cancer cases. Its subtle symptoms pose diagnostic challenges, necessitating intensified research efforts. In the realm of cancer research, ACC is a focal point for unraveling its intricate genetic and molecular underpinnings. Through genomic sequencing, pivotal mutations linked to ACC are identified, unveiling potential therapeutic targets. Moreover, emphasis is laid on refining diagnostic modalities and biomarkers to facilitate early detection and prognosis prediction. Collaborative ventures among researchers and clinicians aim at optimizing treatment paradigms, encompassing surgery, chemotherapy, and radiation therapy, to augment patient outcomes. Despite its rarity, persistent investigative pursuits aim to decode the complexities surrounding ACC, promising advancements in diagnosis, treatment, and patient care.

Committee Members
Speaker at International Cancer Research Conference - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at Oncology Conferences - Michael Thompson

Michael Thompson

University of Toronto, Canada
Speaker at Cancer Research Conferences - Patricia Tai

Patricia Tai

UpToDate, United States
Tags

Submit your abstract Today

Watsapp